Back
Day Range
$25.25
$26.48
52-Week Range
$19.35
$66.85
Volume
870,478
50D / 200D Avg
$28.17
/
$38.37
Prev Close
$25.79
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -15.4 | 0.4 |
| P/B | 4.0 | 2.9 |
| ROE % | -24.9 | 3.8 |
| Net Margin % | -31.0 | 3.9 |
| Rev Growth 5Y % | 72.9 | 10.0 |
| D/E | 0.1 | 0.2 |
Key Takeaways
Revenue grew 72.90% annually over 5 years — strong growth
Debt/Equity of 0.14 — conservative balance sheet
Negative free cash flow of -58.34M
Revenue growth is decelerating — 1Y growth trails 5Y average by 35.68%
Capital efficient — spends only 3.04% of revenue on capex
Growth
Revenue Growth (5Y)
72.90%
Revenue (1Y)37.22%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-24.89%
ROIC-18.66%
Net Margin-31.02%
Op. Margin-33.71%
Safety
Debt / Equity
0.14
Current Ratio6.85
Interest Coverage-11.69
Valuation
P/E Ratio
-15.35
P/B Ratio4.01
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 37.22% | Revenue Growth (3Y) | 50.40% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 72.90% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 308.05M | Net Income (TTM) | -95.57M |
| ROE | -24.89% | ROA | -18.81% |
| Gross Margin | 63.70% | Operating Margin | -33.71% |
| Net Margin | -31.02% | Free Cash Flow (TTM) | -58.34M |
| ROIC | -18.66% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.14 | Current Ratio | 6.85 |
| Interest Coverage | -11.69 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -15.35 | P/B Ratio | 4.01 |
| P/S Ratio | 4.76 | PEG Ratio | 10.70 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.47B | Enterprise Value | 1.23B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 308.05M | 224.50M | 136.19M | 75.01M | 34.47M |
| Net Income | -95.57M | -91.41M | -105.90M | -87.15M | -59.85M |
| EPS (Diluted) | -1.72 | -1.75 | -2.24 | -1.96 | -1.37 |
| Gross Profit | 196.23M | 137.10M | 71.05M | 37.09M | 15.87M |
| Operating Income | -103.86M | -96.61M | -109.17M | -80.72M | -54.16M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 508.08M | 534.02M | 404.72M | 309.33M | 337.02M |
| Total Liabilities | 142.21M | 131.80M | 123.97M | 112.26M | 69.93M |
| Shareholders' Equity | 365.87M | 402.22M | 280.75M | 197.07M | 267.09M |
| Total Debt | 51.62M | 80.25M | 79.20M | 77.32M | 54.10M |
| Cash & Equivalents | 286.50M | 333.73M | 257.22M | 222.64M | 304.32M |
| Current Assets | 450.38M | 481.84M | 350.57M | 272.63M | 326.17M |
| Current Liabilities | 65.80M | 53.13M | 45.93M | 35.29M | 16.24M |